A carregar...
Targeted therapies for renal cell carcinoma: more gains from using them again
The development of molecularly targeted agents that inhibit pathways critical to the development of renal cell carcinoma has significantly improved outcomes in patients with these cancers. Compelling scientific and phase iii data have made the use of molecularly targeted agents the standard of care...
Na minha lista:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Multimed Inc.
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2687802/ https://ncbi.nlm.nih.gov/pubmed/19478898 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|